YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
GALWAY, Ireland, Oct. 7, 2026 /PRNewswire/ -- Medtronic plc (Medtronic; NYSE: MDT) today announced the final exchange ratio for its previously announced offer to exchange outstanding Medtronic ordinary shares for shares of common stock of…
The tax-free exchange offer allows Medtronic investors to swap their shares for MiniMed shares held by Medtronic in what Wall Street calls a split-off. Continue Reading
Dexcom DXCM recently released its 2026 "State of Type 2 Report: Global Access and Attitudes to Diabetes Technology" ahead of the 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD). The report highlights signif…
On September 1, 2026, MiniMed Group, Inc. (NASDAQ:MMED) reported first-quarter fiscal 2027 results for the period ended July 31, 2026. Worldwide net sales rose 16.6% as reported and 15.8% organically to $843 million, U.S. net sales grew 13…
Medtronic shareholders can exchange their Medtronic ordinary shares for shares of MiniMed Provides Medtronic shareholders with option for a generally tax-free exchange for U.S. federal income tax purposes GALWAY, Ireland, Sept. 14, 2026 /P…
NORTHRIDGE, Calif., Sept. 14, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED) announced that it has filed a Form S-4 Registration Statement today with the Securities and Exchange Commission (the "SEC") in connection with Medtronic plc's ("Medt…
On September 1, MiniMed (NASDAQ:MMED) reported its first full quarter as a stand-alone public company, and the numbers suggest the split from Medtronic is already paying off. Revenue jumped 15.8% to $843 million, and management raised its…
Medtronic (NYSE: MDT) has raised its dividend payouts annually for 49 consecutive years. In other words, the medical device company is just one more year and one more hike away from becoming one of just a few dozen Dividend Kings -- public…
Image source: The Motley Fool. DATE Tuesday, Sept. 1, 2026 at 8:45 a.m. ET CALL PARTICIPANTS Vice President and Head of MiniMed Investor Relations - Ryan Weispfenning Chief Executive Officer - Que Dallara Chief Financial Officer - Chad Spo…
Highly specialized medical device maker MiniMed Group (NASDAQ: MMED) was highly prized by investors over the past few trading days. That stood to reason, as the company unveiled first-quarter fiscal 2027 results that comfortably exceeded r…
Medtronic (NYSE: MDT), one of the world's largest medical device makers, was once considered a stable blue chip stock. But over the past five years, it has declined by more than 30% due to supply chain constraints, higher costs, quality co…
Medtronic plc's (MDT) shares rose 1.5% after the company reported first quarter fiscal 2027 revenues of $9,756 million, surpassing the Zacks Consensus Estimate of $9,470.48 million. Shares of MiniMed Group Inc. (MMED) jumped 10.7% after th…
MiniMed Group (NASDAQ:MMED) saw its share price increase by 10.66 percent on Tuesday to finish at $22.42 apiece after reporting strong revenues and earning a price target upgrade from an investment firm. In an earnings call on the same day…
Healthcare stocks were higher Tuesday afternoon, with the NYSE Healthcare Index adding 0.7% and the PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium ne…
Medtronic stock popped Tuesday as its diabetes spinoff MiniMed rallied after both lifted their full-year guidance. Continue Reading
Key Points Interested in MiniMed Group Inc? Here are five stocks we like better. Strong first-quarter growth: MiniMed reported $843 million in fiscal 2027 Q1 revenue, up 15.8% organically, driven by newer insulin pumps and CGM products. Ex…
Medtronic stock advances after the company posts better-than-expected quarterly earnings, raises revenue guidance, and announces a $700 million investment. Continue Reading
The U.S. Food and Drug Administration (FDA) on Tuesday approved Abbott Laboratories' (NYSE:ABT) Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for diabetes patients aged two and older. The regulatory nod makes the device…
Two healthcare innovators, MiniMed Group, Inc. (NASDAQ:MMED) and Abbott Laboratories (NYSE:ABT), hit the spotlight this August with a milestone partnership. On August 17, MiniMed announced that its MiniMed Flex system is commercially shipp…
MiniMed Group, Inc. MMED recently announced that the MiniMed Flex system is now commercially shipping in the United States with Abbott Laboratories' Instinct sensor. The combination brings together the company's smallest and only app-contr…
MiniMed Flex™ with Instinct, made by Abbott, combines discreet design, up to 15 days of sensor wear and proven automation to reduce the work and interruptions of diabetes management NORTHRIDGE, Calif., Aug. 17, 2026 /PRNewswire/ -- MiniMed…
DexCom, Inc. DXCM is entering the second half of 2026 with healthier margins, broader reimbursement and a larger continuous glucose monitoring opportunity. The investment question is whether that improving setup is enough to justify a prem…
DexCom, Inc. DXCM shares have climbed 52.5% in the past three months, a sharp re-rating that raises the standard for further gains. The next leg depends less on momentum alone and more on whether earnings growth, margin expansion and new-m…
Shares of Medtronic (NYSE: MDT), one of the world's largest medical device makers, have declined by more than 30% over the past five years. Higher costs, supply chain bottlenecks, quality control issues, and competitive pressure in surgica…
Key Points Medtronic’s stock has slumped over the past five years. But its restructuring efforts could bring back the bulls.10 stocks we like better than Medtronic › Shares of Medtronic(NYSE: MDT), one of the world's largest medical device…
Key Points Medtronic underperformed the market over the past five years. But it’s still a compelling turnaround play for value-oriented income investors.10 stocks we like better than Medtronic › Medtronic(NYSE: MDT), one of the world's lar…
Medtronic (NYSE: MDT), one of the world's largest medical device makers, was once a reliable blue chip dividend stock. But over the past five years, its stock has declined 33%. Even after including reinvested dividends, it delivered a nega…
MiniMed Group, Inc. MMED recently announced that the MiniMed Flex system is now available to Medicare and Medicare Advantage beneficiaries in the United States. The system was commercially rolled out in the United States for commercially i…
David Endicott, Chief Executive Officer of Alcon, brings global healthcare leadership and public company experience; Linnea Burman adds MedTech operating depth NORTHRIDGE, Calif., June 29, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a glo…
MiniMed MMED recently announced the commercial launch of its MiniMed 780G automated insulin delivery system integrated with Abbott Laboratories' ABT Instinct sensor and the MiniMed Go system integrated with the Instinct Go sensor across Eu…
Medtronic is deeply undervalued and a good bet for your portfolio. At the time, an uncertain growth outlook kept us from recommending the stock. Four months later, it’s time to retire the narrative of Medtronic as a perpetual laggard. Cont…
People with type 1 or insulin-requiring type 2 diabetes in the U.S. can now wear MiniMed's smallest pump, paired with the Simplera Sync™ sensor NORTHRIDGE, Calif., June 17, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), today announced its f…
Key Points The AI craze has left several prominent stocks in other industries on the bargain rack. Consumers drive the economy -- iconic brands across staples and discretionary markets have become dividend stalwarts. This list covers real…
Key Points Interested in Medtronic PLC? Here are five stocks we like better. Medtronic is on track to rebound in the back half of 2026. Solid results, cash flow, and dividends point to a shift in market sentiment. Institutions are buying,…
Illinois-based Abbott ABT extended its solid track record in health-tech innovation by securing the CE Mark for the first-ever dual glucose-ketone sensing technology for people with diabetes. The systems, named Libre Duo and Libre Duo 10 D…
(RTTNews) - Today's gainers list includes ABIVAX, which recently announced positive ulcerative colitis trial results; Cingulate, which is working toward resubmission of a New Drug Application for an ADHD therapy; and Alpha Tau, following i…